title: Chemical digestion and radionuclidic assay of TiNi-encapsulated 32P intravascular brachytherapy sources.
abstract: A very quantitative, destructive assay procedure was devised for accurately measuring the 32P activity content of TiNi-encapsulated intravascular brachytherapy sources and was applied to four different sources (termed 'seeds') which were developed and provided by Guidant Intravascular Intervention (formerly NeoCardia). These seeds are intended for use in the prophylactic treatment of restenosis following balloon angioplasty in heart-disease patients. The assays involved the dissolution of the TiNi jacket, extraction of the activity from the internal 32P-containing source material, quantitative solution transfers, and a gravimetrically based dilution; followed by liquid scintillation (LS) spectrometry of the resulting master solution with 3H-standard efficiency tracing using composition-matched LS cocktails. The LS spectrometry utilized a previously-developed method for resolving the always-present 33P impurity. The protocol included provisions for accounting for all possible losses of 32P in the digestion procedure (based on radiochemical tracing experiments), for any unrecovered activity in the remaining source material, and for any residual activity in the solution-transfer and containing vessels. Sections of the TiNi jackets adjacent to the cut-off active seed portions were also assayed for any contained activity. Such destructive assays were required for relating measurements of the absorbed dose spatial distribution for the seeds to theoretic dose modelling and for establishing calibration factors for subsequent non-destructive radionuclidic measurements on the seeds.
authors.affiliation: Physics Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899-8462, USA. rcolle@nist.gov
authors.forename: R
authors.initials: R
authors.lastname: Collé
mesh_terms: D000497:Alloys; D000800:Angioplasty, Balloon; D001918:Brachytherapy / Q000379:methods*; D002138:Calibration; D003327:Coronary Disease / Q000532:radiotherapy / Q000628:therapy; D006801:Humans; D009532:Nickel / Q000737:chemistry*; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000737:chemistry*; D011877:Radionuclide Imaging; D014025:Titanium / Q000737:chemistry*
chemical_list: D000497:Alloys; D010761:Phosphorus Radioisotopes; C040654:titanium nickelide; D009532:Nickel; D014025:Titanium